Zenith Enzymatic Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 17.26 Cr
- Revenue Growth -12.06%
- Profit Growth -37.06%
- Ebitda 1359.31%
- Net Worth 24.40%
- Total Assets 11.63%
About Zenith Enzymatic Drugs
Zenith Enzymatic Drugs Private Limited (ZEDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 August 2014 and has a history of Ten years and five months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹17.26 Cr.
The Key Managerial Personnel (KMP) at Zenith Enzymatic Drugs Private Limited India is Pranav Gandhi as CEO. Pranav Gandhi, Sharad Ghodekar, and Pradnya Padwal serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999PN2014PTC152169
-
Company No.
152169
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Aug 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
What products or services does Zenith Enzymatic Drugs Private Limited offer?
Zenith Enzymatic Drugs Private Limited offers a wide range of products and services, including Flavours & Aromatics, Food Emulsifiers, Common Disease Medicines, Skin Lightening Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Infective Drugs & Medicines, HIV Drugs, Cardiovascular Drugs & Medication, Cardiac Drugs.
Who are the key members and board of directors at Zenith Enzymatic Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranav Gandhi
|
CEO | 12-Aug-2014 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Pranav Gandhi
|
Director and Ceo | 12-Aug-2014 | Current |
|
Sharad Ghodekar
|
Director | 12-Aug-2014 | Current |
|
Pradnya Padwal
|
Director | 12-Aug-2014 | Current |
Financial Performance of Zenith Enzymatic Drugs.
Zenith Enzymatic Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.06% decrease. The company also saw a substantial fall in profitability, with a 37.06% decrease in profit. The company's net worth Soared by an impressive increase of 24.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenith Enzymatic Drugs?
Unlock access to Zenith Enzymatic Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Eragina Digital Solutions Private LimitedPranav Gandhi is a mutual person
-
Thezensocio Techconsulting Private Limited
Pranav Gandhi is a mutual person
Charges (Loans)
₹172.56 M
₹0
Charges Breakdown by Lending Institutions
- Others : 17.26 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2023 | Others | ₹4.95 Cr | Open |
| 30 Dec 2023 | Others | ₹5.05 Cr | Open |
| 04 Jul 2017 | Others | ₹7.26 Cr | Open |
How Many Employees Work at Zenith Enzymatic Drugs?
Zenith Enzymatic Drugs has a workforce of 23 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenith Enzymatic Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenith Enzymatic Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.